Signaling thresholds and interclonal competition in preimmune B-cell selection

Immunological Reviews

Volumn 156, Issue , 1997, Pages 87-101

  Cyster, Jason G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; LYMPHOCYTE RECEPTOR; PROTEIN TYROSINE PHOSPHATASE;

AUTOIMMUNITY; B LYMPHOCYTE; CELL DEATH; CELL SELECTION; CELL SURVIVAL; HUMAN; IMMUNOCOMPETENT CELL; LYMPH NODE; LYMPHOCYTE CLONE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SPLEEN;

EID: 0031004822     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00961.x     Document Type: Review

References (142)

1. Goodnow CC, et al. Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 1995;59:279-368.
2. Dighiero G, et al. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 1983;131:2267-2272.
3. Prabhakar BS, Saegusa J, Onodera T, Notkins AL. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 1984;133:2815-2817.
4. Ternynck T, Avrameas S. Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol Rev 1986;94:99-112.
5. Casali P, Notkins AL. Probing the human B cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Ann Rev Immunol 1989;7:513-535.
6. Rousseau PG, Mallett CP, Smith-Gill SJ. A substantial proportion of the adult balb/c available B cell repertoire consists of multireactive B cells. Molec Immunol 1989;26:993-1006.
7. Souroujon M, White-Scharff ME, Andre-Schwartz J, Gefter ML, Schwartz RS. Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J Immunol 1988;140:4173-4179.
8. Striebich CC, Miceli RM, Schulze DH, Kelsoe G, Cerny J. Antigen-binding repertoire and Ig H chain gene usage among B cell hybridomas from normal and autoimmune mice. J Immunol 1990;144:1857-1865.
9. Kearney JF, Bartels J, Hamilton AM, Lehuen A, Solvason N, Vakil M. Development and function of the early B cell repertoire. Int Rev Immunol 1992;8:247-257.
10. Strong RK, Petsko GA, Sharon J, Margolies MN. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 2. Structural basis of hapten binding and idiotypy. Biochemistry 1991;30:3749-3757.
11. Hartley SB, Goodnow CC. Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme specific antibody. Int Immunol 1994;6:1417-1425.
12. Patten PA, et al. The immunological evolution of catalysis. Science 1996;271:1086-1091.
13. Lang J, Jackson M, Teyton L, Brunmark A, Kane K, Nemazee D. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med 1996;184:1685-1698.
14. Foote J, Milstein C. Conformational isomerism and the diversity of antibodies. Proc Natl Acad Sci USA 1994;91:10370-10374.
15. Nemazee D. Antigen receptor 'capacity' and the sensitivity of self-tolerance. Immunol Today 1996;17:25-29.
16. Goodnow CC, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
17. Mason DY, Jones M, Goodnow CC. Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int Immunol 1992;4:163-175.
18. Adelstein S, et al. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science 1991;251:1223-1225.
19. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991;353:765-769.
20. Cooke MP, et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 1994;179:425-438.
21. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993;177:999-1008.
22. Chen C, et al. The site and stage of anti-DNA B-cell elimination. Nature 1995;373:252-255.
23. Okamoto M, et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992;175:71-79.
24. Nemazee DA, Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989;337:562-566.
25. Hartley SB, et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993;72:325-335.
26. Green MC, Shultz LD. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J Hered 1975;66:250-258.
27. Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL. "Viable motheaten", a new allele at the motheaten locus. I. Pathology. Am J Pathol 1984;116:179-192.
28. Shultz LD, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993;73:1445-1454.
29. Tsui HW, Siminovitch KA, de Souza L, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 1993;4:124-129.
30. Shen SH, Bastien L, Posner BI, Chretien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991;352:736-739.
31. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992;12:2396-2405.
32. Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992;89:1123-1127.
33. Yi T, Cleveland JL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 1992;12:836-846.
34. Pei D, Neel BG, Walsh CT. Overexpression, purification, and characterization of SHPTP1, a Src homology 2-containing protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 1993;90:1092-1096.
35. Kozlowski M, Mlinaric RI, Feng GS, Shen R, Pawson T, Siminovitch KA. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med 1993;178:2157-2163.
36. Hayashi S, Witte PL, Shultz LD, Kincade PW. Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice. J Immunol 1988;140:2139-2147.
37. Shultz LD. Hematopoiesis and models of immunodeficiency. Semin Immunol 1991;3:397-408.
38. Shultz LD, Green MC. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J Immunol 1976;116:936-943.
39. Sidman CL, Shultz LD, Unanue ER. The mouse mutant "motheaten". I. Development of lymphocyte populations. J Immunol 1978;121:2392-2398.
40. Davidson WF, Morse HC III, Sharrow SO, Chused TM. Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. J Immunol 1979;122:884-891.
41. Sidman CL, Shultz LD, Hardy RR, Hayakawa K, Herzenberg LA. Production of immunoglobulin isotypes by Ly-1 + B cells in viable motheaten and normal mice. Science 1986;232:1423-1425.
42. Painter CJ, et al. Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice. J Exp Med 1988;167:1137-1153.
43. Katsuri KN, Mayer R, Bona CA, Scott VE, Sidman CL. Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells. J Immunol 1990;145:2304-2311.
44. Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995;2:13-24.
45. Medlock ES, Goldschneider I, Greiner DL, Shultz LD. Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro. J Immunol 1987;138:3590-3597.
46. Bell SE, Goodnow CC. A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J 1994;13:816-826.
47. Tonks NK, Neel BG. From form to function: signaling by protein tyrosine phosphatases. Cell 1996;87:365-368.
48. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995;80:729-738.
49. David M, Chen HE, Goelz S, Larner AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Molec Cell Biol 1995;15:7050-7058.
50. Lorenz U, et al. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-kit by the protein tyrosine phosphatase SHP1. J Exp Med 1996;184:1111-1126.
51. Paulson RF, Vesely S, Siminovitch KA, Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nature Genetics 1996;13:309-315.
52. Burshtyn DN, et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77-85.
53. Doody GM, et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995;269:242-244.
54. D'Ambrosio D, et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science 1995;268:293-297.
55. O'Keefe TL, Williams GT, Davies SL, Neuberger MS. Hyperresponsive B cells in CD22-deficient mice. Science 1996;274:798-801.
56. Pingel JT, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 1989;58:1055-1065.
57. Koretzky GA, Picus J, Thomas ML, Weiss A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 1990;346:66-68.
58. Peyron J-F, Verma S, de Waal Malefyt R, Sancho J, Terhorst C, Spits H. The CD45 protein tyrosine phosphatase is required for the completion of the activation program leading to lymphokine production in the Jurkat human T cell line. Int Immunol 1991;3:1357-1366.
59. Shiroo M, Lindsey G, Biffen M, Shivnan E, Alexander D. CD45 tyrosine phosphatase-activated p59fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx. EMBO J 1992;11:4887-4897.
60. Volarevic S, et al. The CD45 tyrosine phosphatase regulates phosphotyrosine homeostasis and its loss reveals a novel pattern of late T cell receptor-induced Ca2+ oscillations. J Exp Med 1992;176:835-844.
61. Justement LB, Campbell KS, Chien NC, Cambier JC. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 1991;252:1839-1842.
62. Ogimoto M, Katagiri T, Mashima K, Hasegawa K, Mizuno K, Yakura H. Antigen receptor-initiated growth inhibition is blocked in CD45-loss variants of a mature B lymphoma, with limited effects on apoptosis. Eur J Immunol 1995;25:2265-2271.
63. Chui D, Ong CJ, Johnson P, Teh H-S, Marth JD. Specific CD45 isoforms differentially regulate T cell receptor signaling. EMBO J 1994;13:798-807.
64. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994;12:85-116.
65. Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 1994;12:555-592.
66. Cambier JC, Pleiman CM, Clark MR. Signal transduction by the B cell antigen receptor and its coreceptors. Ann Rev Immunol 1994;12:457-486.
67. Kishihara K, et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phophatase-deficient mice. Cell 1993;74:143-156.
68. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. Regulation of B-lymphocyte negative and positive selection by tryosine phosphatase CD45. Nature 1996;381:325-328.
69. Cyster JG, Hartley SB, Goodnow CC. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 1994;371:389-395.
70. Perlmutter RM. Programmed development of the antibody repertoire. Curr Top Microbiol Immunol 1987;135:95-109.
71. H genes occurs in the newly generated repertoire of neonatal and adult mice. J Exp Med 1990;171:843-859.
72. H gene repertoires: differentiating B cells of adult bone marrow mimic fetal development. Int Immunol 1990;2:15-23.
73. H81X gene segments evidences a dependence of B cell clonal maturation on the structure of nascent H chains. J Immunol 1991;147:1406-1411.
74. Gu H, Tarlinton D, Muller W, Rajewsky K, Forster I. Most peripheral B cells in mice are ligand selected. J Exp Med 1991;173:1357-1371.
75. Huetz F, Carlsson L, Tornberg U-C, Holmberg D. V-region directed selection in differentiating B lymphocytes. EMBO J 1993;12:1819-1826.
76. Pandey A, Tjoelker LW, Thompson CB. Restricted immunoglobulin junctional diversity in neonatal B cells results from developmental selection rather than homology-based V(D)J joining. J Exp Med 1993;177:329-337.
77. Reynaud CA, Garcia C, Hein WR, Weill JC. Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process. Cell 1995;80:115-125.
78. Ye J, McCray SK, Clarke SH. The majority of murine Vh 12-expressing B cells are excluded from the peripheral repertoire in adults. Eur J Immunol 1995;25:2511-2521.
79. Benatar T, Carsetti R, Furlonger C, Kamalia N, Mak T, Paige CJ. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med 1996;183:329-334.
80. McCall MN, Shotton DM, Barclay AN. Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies. Immunol 1992;76:310-319.
81. Reth M. Antigen receptors on B lymphocytes. Ann Rev Immunol 1992;10:97-121.
82. Torres RM, Flaswinkel H, Reth M, Rajewsky K. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 1996;272:1804-1808.
83. Bargatze RF, Butcher EC. Rapid G protein regulated activation event involved in lymphocyte binding to high endothelial venules. J Exp Med 1993;178:367-372.
84. Girard J-P, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-457.
85. Gallatin WM, Weissman IL, Butcher EC. A cell surface molecule involved in organ-specific homing of lymphocytes. Nature 1983;304:30-34.
86. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992;10:561-591.
87. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
88. Sprent J. Circulating T and B lymphocytes of the mouse I. Migratory properties. Cell Immunol 1973;7:10-39.
89. Nieuwenhuis P, Ford WL. Comparative migration of B- and T-Lymphocytes in the rat spleen and lymph nodes. Cell Immunol 1976;23:254-267.
90. van Ewijk W, Nieuwenhuis P. Compartments, domains and migration pathways of lymphoid cells in the splenic pulp. Experientia 1985;41:199-208.
91. Weiss L. Mechanisms of splenic clearance of the blood: A structural overview of the mammalian spleen. In: Bowdler AJ. The spleen. Structure, function and clinical significance. London: Chapman and Hall Medical, 1990:23-44.
92. Groom AC, Schmidt EE. Microcirculatory blood flow through the spleen. In: Bowdler AJ. The spleen. Structure, function and clinical significance. London: Chapman and Hall Medical, 1990:45-102.
93. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytology 1992;132:31-73.
94. Cyster JG, Goodnow CC. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 1995;182:581-586.
95. Lyons AB, Parish CR. Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur J Immunol 1995;25:3165-3172.
96. Sprent J, Miller JFAP. Thoracic duct lymphocytes from nude mice: migratory properties and life-span. Eur J Immunol 1972;2:384-388.
97. Gutman GA, Weissman IL. Homing properties of thymus-independent follicular lymphocytes. Transplantation 1973;16:621-629.
98. Nieuwenhuis P, Ford WL. Comparative migration of B- and T-lymphocytes in the rat spleen and lymph nodes. Cell Immunol 1976;23:254-267.
99. Kuppers R, Zhao M, Hansmann M-L, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993;12:4955-4967.
100. Nossal GJV, Ada GL. Antigens, lymphoid cells and the immune response. New York: Academic Press, 1971.
101. Veerman AJ, van Ewijk W. White pulp compartments in the spleen of rats and mice. A light and electron microscopic study of lymphoid and non-lymphoid cell types in T-and B- areas. Cell Tissue Res 1975;156:417-441.
102. Mandel TE, Phipps RP, Tew JG. The follicular dendritic cell: Long term antigen retention during immunity. Immunol Rev 1980;53:29-57.
103. Cyster JG, Goodnow CC. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 1995;3:691-701.
104. Fulcher DA, et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 1996;183:2329-2336.
105. Claassen E, Kors N, Van Rooijen N. Influence of carriers on the development and localization of anti-trinitrophenyl antibody forming cells in the murine spleen. Eur J Immunol 1986;16:271-276.
106. Liu Y-J, Oldfield S, MacLennan ICM. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 1988;18:355-362.
107. Liu Y-J, Zhang J, Lane PJL, Chan EY-T, MacLennan ICM. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991;21:2951-2962.
108. Jacob J, Kassir R, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med 1991;173:1165-1175.
109. Jacob J, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 1992;176:679-687.
110. Smith KGC, Hewitson TD, Nossal GJV, Tarlinton DM. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol 1996;26:444-448.
111. MacLennan ICM. Germinal centers. Annu Rev Immunol 1994;12:117-139.
112. Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 1989;342:385-391.
113. Fulcher DA, Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med 1994;179:125-134.
114. Cornall RJ, Goodnow CC, Cyster JG. The regulation of self-reactive B cells. Curr Opin Immunol 1995;7:804-811.
115. Tough DF, Sprent J. Lifespan of lymphocytes. Immunologic Research 1995;14:1-12.
116. Tsukada S, Rawlings DJ, Witte ON. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Op Immunol 1994;6:623-630.
117. Hendriks RW, DeBruijn MFTR, Maas A, Dingjan GM, Karis A, Grosveld F. Inactivation of Btk by insertion of lacZ reveals defects in B cell develoment only past the pre-B cell stage. EMBO J 1996;15:4862-4872.
118. Oka Y, et al. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int Immunol 1996;8:1675-1685.
119. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87:1-20.
120. Togni PD, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994;264:703-707.
121. Eugster H-P, et al. Multiple abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int Immunol 1996;8:23-36.
122. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 1996;271:1289-1291.
123. + T cells. Nature 1995;376:181-184.
124. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996;87:319-329.
125. Brahim F, Osmond DG. Migration of bone marrow lymphocytes demonstrated by selective bone marrow labeling with thymidine-H3. Anat Rec 1970;168:139-159.
126. Chan EY-T, MacLennan ICM. Only a small proportion of splenic B cells in adults are short-lived virgin cells. Eur J Immunol 1993;23:357-363.
127. Allman DM, Ferguson SE, Lentz VM, Cancro MP. Peripheral B cell maturation II. Heat-stable antigen high splenic B cells are an immature developmental intermediate in the production of long-lived marrow derived cells. J Immunol 1993;151:4431-4444.
128. Bazin H, Platteau B, MacLennan ICM, Johnson GD. B-cell production and differentiation in adult rats. Immunology 1985;54:79-88.
129. Lane PJL, Gray D, Oldfield S, MacLennan ICM. Differences in the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens. Eur J Immunol 1986;16:1569-1575.
130. Sprent J, Basten A. Circulating T and B lymphocytes of the mouse. II. Lifespan. Cellular Immunology 1973;7:40-59.
131. Gray D. Population kinetics of rat peripheral B cells. J Exp Med 1988;167:805-816.
132. Forster I, Vieira P, Rajewsky K. Flow cytometric analysis of cell proliferation dynamics in the B cell compartment of the mouse. Int Immunol 1989;1:321-331.
133. Forster I, Rajewsky K. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci USA 1990;87:4781-4784.
134. Lortran JE, Roobottom CA, Oldfield S, MacLennan ICM. Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. Eur J Immunol 1987;17:1311-1316.
135. Ross SE, Simecka JW, Gambill GP, Davis JK, Cassell GH. Mycoplasma pulmonis possess a novel chemoattractant for B lymphocytes. Infect Immunity 1992;60:669-674.
136. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995;13:179-200.
137. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-318.
138. Ochs HD, Wedgwood RJ. Disorders of the B-cell system. In: Stiehm ER. Immunologic disorders in infants and children. Philadelphia: Saunders, 1989:226-256.
139. Penhale WJ, Farmer A, Irvine WJ. Thyroiditis in T cell depleted rats. Clin Exp Immunol 1975;21:362-375.
140. Rose NR, Kong Y-CM, Okayasu I, Giraldo AA, Beisel K, Sundick RS. T cell regulation in autoimmune thyroiditis. Immunol Rev 1981;55:299-314.
141. + T cell subset that inhibits this autoimmune potential. J Exp Med 1993;177:627-636.
142. Shokat KM, Goodnow CC. Antigen-induced B-cell death and elimination during germinal center immune responses. Nature 1995;375:334-338.